Page 145 - Read Online
P. 145

Akinci et al. Vessel Plus 2021;5:56  https://dx.doi.org/10.20517/2574-1209.2021.20  Page 17 of 20

               Copyright
               © The Author(s) 2021.


               REFERENCES
               1.       Rajashekar D, Liang JW. Intracerebral hemorrhage. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021.
                   PubMed
               2.       Qureshi AI, Mendelow AD, Hanley DF. Intracerebral haemorrhage. Lancet 2009;373:1632-44.  DOI  PubMed  PMC
               3.       Ziai WC, Carhuapoma JR. Intracerebral hemorrhage. Continuum (Minneap Minn) 2018;24:1603-22.  DOI  PubMed
               4.       McEvoy AW, Kitchen ND, Thomas DG. Lesson of the week: intracerebral haemorrhage in young adults: the emerging importance of
                   drug misuse. BMJ 2000;320:1322-4.  DOI  PubMed  PMC
               5.       Aguilar MI, Freeman WD. Spontaneous intracerebral hemorrhage. Semin Neurol 2010;30:555-64.  DOI  PubMed
               6.       Qureshi AI, Qureshi MH. Acute hypertensive response in patients with intracerebral hemorrhage pathophysiology and treatment. J
                   Cereb Blood Flow Metab 2018;38:1551-63.  DOI  PubMed  PMC
               7.       Davis SM, Broderick J, Hennerici M, et al; Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators.
                   Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology 2006;66:1175-81.  DOI
                   PubMed
               8.       Majidi S, Suarez JI, Qureshi AI. Management of acute hypertensive response in intracerebral hemorrhage patients after ATACH-2
                   trial. Neurocrit Care 2017;27:249-58.  DOI  PubMed
               9.       Terayama Y, Tanahashi N, Fukuuchi Y, Gotoh F. Prognostic value of admission blood pressure in patients with intracerebral
                   hemorrhage. Keio Cooperative Stroke Study. Stroke 1997;28:1185-8.  DOI  PubMed
               10.      Fujii Y, Takeuchi S, Sasaki O, Minakawa T, Tanaka R. Multivariate analysis of predictors of hematoma enlargement in spontaneous
                   intracerebral hemorrhage. Stroke 1998;29:1160-6.  DOI  PubMed
               11.      Ohwaki K, Yano E, Nagashima H, Hirata M, Nakagomi T, Tamura A. Blood pressure management in acute intracerebral hemorrhage:
                   relationship between elevated blood pressure and hematoma enlargement. Stroke 2004;35:1364-7.  DOI  PubMed
               12.      Sang YH, Su HX, Wu WT, So KF, Cheung RT. Elevated blood pressure aggravates intracerebral hemorrhage-induced brain injury. J
                   Neurotrauma 2011;28:2523-34.  DOI  PubMed  PMC
               13.      Dastur CK, Yu W. Current management of spontaneous intracerebral haemorrhage. Stroke Vasc Neurol 2017;2:21-9.  DOI  PubMed
                   PMC
               14.      Biffi A, Anderson CD, Battey TW, et al. Association between blood pressure control and risk of recurrent intracerebral hemorrhage.
                   JAMA 2015;314:904-12.  DOI  PubMed  PMC
               15.      Qureshi AI, Ezzeddine MA, Nasar A, et al. Prevalence of elevated blood pressure in 563,704 adult patients with stroke presenting to
                   the ED in the United States. Am J Emerg Med 2007;25:32-8.  DOI  PubMed  PMC
               16.      Brott T, Thalinger K, Hertzberg V. Hypertension as a risk factor for spontaneous intracerebral hemorrhage. Stroke 1986;17:1078-83.
                   DOI  PubMed
               17.      Qureshi AI. Acute hypertensive response in patients with stroke: pathophysiology and management. Circulation 2008;118:176-87.
                   DOI  PubMed
               18.      Fischer U, Cooney MT, Bull LM, et al. Acute post-stroke blood pressure relative to premorbid levels in intracerebral haemorrhage
                   versus major ischaemic stroke: a population-based study. Lancet Neurol 2014;13:374-84.  DOI  PubMed  PMC
               19.      Kazui S, Minematsu K, Yamamoto H, Sawada T, Yamaguchi T. Predisposing factors to enlargement of spontaneous intracerebral
                   hematoma. Stroke 1997;28:2370-5.  DOI  PubMed
               20.      Mayer SA, Brun NC, Begtrup K, et al; FAST Trial Investigators. Efficacy and safety of recombinant activated factor VII for acute
                   intracerebral hemorrhage. N Engl J Med 2008;358:2127-37.  DOI  PubMed
               21.      de Gasparo M, Speth RC, Baltatu OC, Vanderheyden P. Brain RAS: hypertension and beyond. Int J Hypertens 2013;2013:157180.
                   DOI  PubMed  PMC
               22.      Morishita R, Higaki J, Okunishi H, et al. Role of tissue renin angiotensin system in two-kidney, one-clip hypertensive rats. Am J
                   Physiol 1993;264:F510-4.  DOI  PubMed
               23.      Kamińska M, Mogielnicki A, Stankiewicz A, Kramkowski K, Domaniewski T, Buczko W, Chabielska E. Angiotensin II via AT1
                   receptor accelerates arterial thrombosis in renovascular hypertensive rats. J Physiol Pharmacol 2005;56:571-85.  PubMed
               24.      Wakisaka Y, Chu Y, Miller JD, Rosenberg GA, Heistad DD. Critical role for copper/zinc-superoxide dismutase in preventing
                   spontaneous intracerebral hemorrhage during acute and chronic hypertension in mice. Stroke 2010;41:790-7.  DOI  PubMed  PMC
               25.      Wakisaka Y, Chu Y, Miller JD, Rosenberg GA, Heistad DD. Spontaneous intracerebral hemorrhage during acute and chronic
                   hypertension in mice. J Cereb Blood Flow Metab 2010;30:56-69.  DOI  PubMed  PMC
               26.      Ito H, Takemori K, Suzuki T. Role of angiotensin II type 1 receptor in the leucocytes and endothelial cells of brain microvessels in the
                   pathogenesis of hypertensive cerebral injury. J Hypertens 2001;19:591-7.  DOI  PubMed
               27.      Lanz TV, Ding Z, Ho PP, et al. Angiotensin II sustains brain inflammation in mice via TGF-beta. J Clin Invest 2010;120:2782-94.
                   DOI  PubMed  PMC
               28.      Wosik K, Cayrol R, Dodelet-Devillers A, et al. Angiotensin II controls occludin function and is required for blood brain barrier
                   maintenance: relevance to multiple sclerosis. J Neurosci 2007;27:9032-42.  DOI  PubMed  PMC
               29.      Miyoshi M, Miyano K, Moriyama N, Taniguchi M, Watanabe T. Angiotensin type 1 receptor antagonist inhibits lipopolysaccharide-
                   induced stimulation of rat microglial cells by suppressing nuclear factor kappaB and activator protein-1 activation. Eur J Neurosci
   140   141   142   143   144   145   146   147   148   149   150